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A simple, rapid and sensitive spectrophotometric method for the determination of isoniazid (INH) and
ritodrine hydrochloride (RTH) in pure form as well as dosage forms is described. The method is based on
the diazotisation of 4,40 -sulphonyldianiline (dapsone, DAP) followed by a coupling reaction with either
INH or RTH in sodium hydroxide medium. Beer’s law is obeyed in the concentration range of 0.5-20 µg
ml−1 for INH at 440 nm and 0.5-18 µg ml−1 for RTH at 460 nm. The method is successfully employed
for the determination of INH/RTH in pharmaceutical preparations and the results agree favourably
with the official and reported methods. Common excipients used as additives in pharmaceuticals do not
interfere in the proposed method. The method offers the advantages of simplicity, rapidity and sensitivity
without the need for extraction or heating. Limit of detection (LOD) and limit of quantification (LOQ)
are reported.
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Pyridine-4-carboxylic acid hydrazide, commercially known as isoniazid (INH), is an antitubercular
drug and is now widely used together with rifampicin and streptomycin for the chemotherapy of tuberculosis.
Ritodrine hydrochloride (RTH), chemically, 1-(4-hydroxyphenyl)-2-[2-(4-hydroxyphenyl)ethylamino]propanol
is a potent tocolytic drug and is a selective β2-adrenoceptor agonist and is used to control premature labour
and to reverse foetal distress caused by excessive uterine activity.
The importance of these two drugs has prompted many investigators to devise methods for the
rapid determination of INH/RTH in its pure form as well as in pharmaceutical preparations. There are
various analytical procedures for the assay of INH, may of which were reviewed in one of our earlier
works on the spectrophotometric determination of isoniazid1 . The spectrophotometric reagents for the
determination of isoniazid include sodium 1,2-naphthoquinone-4-sulphonate and cetyltrimethyl ammonium
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bromide1 , vanadophosphoric acid2 , 2,5-diphenyl-3-thiazolyltetrazolium chloride3 , o-hydroxyquinolphthaleinPd(II)-hexadecyl trimethyl ammonium chloride complex4 , 6,7-dichloroquinoline-5,8-dione5, 1-fluoro-2,4dinitrobenzene6 , p-benzoquinone7 , chloranil or bromanil8, Fe(II) and 2,20 -dipyridyl9, tetrazolium blue
chloride10 , ethyl 8-quinolyloxyacetate11 and N-bromosuccinimide with celestine blue12 . The reported analytical procedures for the estimation of RTH in bulk samples and in unit dosage forms are reviewed in a
recent spectrophotometric work for the determination of RTH13. The other spectrophotometric reagents for
RTH include 3-methylbenzothiazolin-2-one hydrazone (MBTH)-Ce(IV)14 and 4-aminoantipyrine with phenols in the presence of an alkaline oxidising agent15 . The recent three methods13−15 for the determination of
RTH makes use of an oxidizing agent like Ce(IV) or chloramine-T(CAT) along with reagents like MBTH,
N,N-dimethylamino- paraphenylenediamine (DMPD), 4-aminophenazone and 4-aminoantipyrine. There are
several oxidising agents which give colour with these reagents and MBTH is becoming a universal reagent
for the determination of various drugs. The reported methods13,14 make use of MBTH-Ce(IV), as MBTH is
not economical and the results are inconsistent. Bakry et al.16 have determined RTH with 2,6-dihaloquinone
chlorimides. Both isoniazid and ritodrine hydrochloride are listed in the United States Pharmacopoeia17,18.
In continuation of our work19−26 on the spectrophotometric determination of organic compounds of
pharmaceutical importance, the present work reports an elegant method for the determination of INH/RTH
in pure form or in pharmaceutical preparations. The method is based on the diazotisation of DAP followed
by a coupling reaction with either INH or RTH in alkaline medium. The method does not make use of any
oxidising agent and avoids heating or extraction. This colour reaction is being reported for the first time.

Experimental
A JASCO MODEL UVIDEC-610 UV-VIS spectrophotometer with 1.0 cm matched cells was used for
absorbance measurements. INH (BDH, Poole, England), RTH (Duphar-Interfran Ltd., Mumbai, India),
and DAP (Sigma, USA) were used without further purification. Sodium nitrite (BDH), sodium hydroxide
(GR), hydrochloric acid (AR) and all other reagents and solvents were of analytical grade. Commercial
dosage forms were purchased from local sources.
Deionised water was used to prepare all solutions. Standard solutions of INH or RTH (1000 µg ml−1)
were prepared by dissolving 100 mg of drug in water and then diluting to the mark in a 100 ml volumetric
flask. A working standard solution of the drug containing either 25 or 50 µg ml−1 was prepared by further
dilution. Isoniazid and ritodrine hydrochloride solutions were standardised by the official method17 and
2,6-dihaloquinone chlorimide method16 respectively. A 0.2% solution of dapsone in water (add 1 ml of dilute
hydrochloric acid), 1% solution of sodium nitrite in water, 2% sulphamic acid solution, 5 N hydrochloric
acid solution and a solution of 5 N sodium hydroxide were used.

Recommended Procedure
For Pure INH or RTH
Three millilitres of 0.2% solution of dapsone was taken in a series of 25 ml standard flasks. A 5 N solution
of hydrochloric acid (0.5 ml) was added to the dapsone solutions and cooled for 5 min in an ice bath. Then
1 ml of a 1% solution of sodium nitrite was added to each flask with swirling. It was cooled for 5 min and
then 2 ml of 2% sulphamic acid was added. The solutions were swirled and allowed to stand for 5 min.
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Then, INH solution (12.5-500 µg) or RTH solution (12.5-450 µg) was added followed by the addition of 2
ml of 5 N sodium hydroxide solution, made up to the mark with water, mixed thoroughly and after 5 min
the absorbance was measured at 440 and 460 nm respectively for INH and RTH against the corresponding
reagent blank and the calibration graph was constructed.
For dosage forms
Twenty tablets were weighed and finely powdered. A powdered amount equivalent to 50 mg was dissolved in
water (dilute hydrochloric acid for RTH) and filtered (for the syrup or injection, an appropriate volume was
taken). The filtrate was made up to 100 ml and appropriate aliquots of the tablet/syrup/injection solutions
were treated as described in the recommended procedure for pure samples.

Results and Discussion
The method involves the diazotisation of dapsone followed by coupling with INH or RTH in an alkaline
medium to produce a yellow (for INH) or orange yellow (for RTH) product.

Spectral characteristics
The absorption spectra of the yellow product (1) with maximum absorption at 440 nm and of the orange
yellow product (2) with maximum absorption at 460 nm are shown in the Figure. The colourless reagent
blank has practically negligible absorption at these wavelengths in both cases. The optical characteristics
and precision data for both methods are given in Table 1.
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Figure. Absorption spectra of the reaction product (1) of INH with DAP and of reaction product (2) of
RTH with DAP. Final drug concentration = 10 µg ml−1 .

Optimum reagent concentrations
It was found that a 0.2% solution of dapsone in the range of 2-4 ml, a 5 N solution of hydrochloric acid in the
range of 0.25-1.0 ml, a 1% solution of sodium nitrite in the range of 0.5-2.0 ml, a 2% solution of sulphamic
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acid in the range of 1-3 ml and 1-3 ml of 5 N NaOH solution were necessary to achieve maximum colour
intensity with both INH and RTH. Hence, the required volumes of all the reagents and solutions were used
(as mentioned in the recommended procedure) to produce the coloured product. The excess of nitrite during
diazotisation could be removed by the addition of sulphamic acid solution and an excess of sulphamic acid
solution has no effect on the colour intensity.
Table 1. Optical characteristics and precision data

Parameters / Characteristics
Colour
λ max (nm)
Stability (Hrs)
Beer’s law range (µg ml−1)
Limit of detection (µg ml−1 )
Limit of quantification (µg ml−1 )
Molar absorptivity (l mol−1 cm−1 )
Sandell’s sensitivity (µg cm−2 )
Optimum photometric range (µg ml−1 )
Regression equation (Y = bx + a, where x
is the concentration in µg ml−1 )
Slope (b)
Intercept (a)
Correlation coefficient (r)
Relative standard deviation (%) for n = 10
Range of error (%)

INH - DAP
Yellow
440
01
0.5-20
0.3243
1.0811
5.729 x 103
0.0239
0.7-18

RTH – DAP
Orange yellow
460
72
0.5-18
0.2182
0.7274
1.163 x 104
0.02471
0.8-16

0.0259
0.0473
0.9961
0.35
±0.4908

0.03593
0.00588
0.9998
0.45
±0.6196

Reaction sequence
For the diazotisation process, dapsone could be readily diazotised in acidic medium and each diazonium
cation would then react with a molecule of INH or RTH by electrophilic substitution at the position ortho to
the hydrazide group (INH) or ortho to the phenolic hydroxyl group (RTH), and this results in the formation
of the coloured products. An investigation of the continuous molar variation of the INH/RTH and DAP
showed that the drug interacts with DAP at a ratio of 2:1. Similar results have been observed with the mole
ratio method. A reaction sequence based on the above results is shown in the Scheme.

Stability of the products
The yellow product (INH-DAP) was stable for about 1 h. The orange yellow product (RTH-DAP) was stable
for more than 3 days. Attempts to increase the stability of the yellow product beyond 1 h were unsuccessful.
This was done by varying the concentrations and volumes of all the reagents involved in the experiment. A
temperature range of 20-30◦C is preferred for both coupling reactions.

Quantification, accuracy and precision
The validity of the proposed procedure for the determination of the studied drugs in their pure state and
in their pharmaceutical formulations was tested by analysing these drugs using the proposed procedure and
the official methods17,18 . The results obtained for pure drugs (Table 1) were reproducible with low relative
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standard deviations (0.35-0.45%) and the mean recoveries were comparable to those obtained using the
official methods for each of the studied drugs.
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Scheme
LOQ is determined by taking the ratio of standard deviation (σ) of the blank with respect to water
and the slope of calibration curve (s) multiplied by a factor of 10. This means that LOQ is approximately
3.3 times LOD. Naturally, the LOQ slightly crosses the lower limit of Beer’s law range. However, LOD is
well below the lower limit of Beer’s law range. The upper limit of the Beer-Lambert range is determined by
a plot of absorbance against concentration at the value of λmax . Beyond this limit, the correlation results
were strongly affected. Hence, the measurements were excluded above these limits to keep the relationship
linear.

Statistical analysis of the results in comparison with the official method
The performance of the proposed method was compared statistically in terms of Student’s t-test and the
variance ratio F-test. At 95% confidence level, the calculated t-values and F-values do not exceed the
theoretical values for either INH or RTH. The theoretical t-value was 2.776 (for n = 5) and F-value was
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6.39 (for n = 5). Therefore, there is no significant difference between the proposed method and the official
method, indicating that the proposed method is as accurate and precise as the official method.

Interference
The extent of interference by some excipients which often accompany pharmaceutical preparations were
determined by measuring the absorbance of solutions containing 10 µg ml−1 of INH or RTH and various
amounts of diverse species. It was found that the excipients studied do not interfere in the present method,
even when present in excess. An error of 2.0% in the absorbance readings was considered tolerable. Typical
results are given in Table 2.
Table 2. Determination of INH/RTH (10 µg/ml of drug taken) in presence of excipients

Excipient
Talc
Gum acacia
Sodium chloride
Glucose
Lactose
Sodium alginate
Carboxy methylcellulose
Magnesium stearate
Starch
Dextrose
Vitamin-B6

Excipient taken (µg/ml)
50000
50000
50000
35000
35000
40000
40000
40000
50000
40000
20000

% Recovery of drug ± % RSD (n = 5)
INH
RTH
99.7 ± 0.3
99.6 ± 0.35
99.5 ± 0.25
99.4 ± 0.3
99.6 ± 0.35
99.5 ± 0.4
100.4 ± 0.25
100.2 ± 0.3
100.5 ± 0.28
99.8 ± 0.4
99.2 ± 0.28
99.3 ± 0.3
99.4 ± 0.35
99.5 ± 0.4
99.5 ± 0.3
99.7 ± 0.25
99.6 ± 0.35
99.9 ± 0.35
100.3 ± 0.25
100.4 ± 0.4
99.3 ± 0.35
99.4 ± 0.45

Application
The reproducibility of the method was checked by 10 replicate determinations at 10 µg ml−1 level of INH
or RTH and the maximum relative standard deviation (%) was found to be 0.45. The present method has
been successfully employed for the analysis of INH or RTH in commercial dosage forms. The results of
the analysis of pharmaceutical preparations are given in Table 3 and compare favourably with those of the
official methods17,18 .

Conclusion
The proposed method is found to be simple, rapid and economical and will compete with most of the
spectrophotometric methods available in the literature. The proposed method is advantageous over many
spectrophotometric methods, as heating or extraction is avoided. The method has a higher sensitivity
and stability than some of the spectrophotometric methods available and is sufficiently sensitive to permit
determination even up to 0.5 µg ml−1 . The method does not make use of any oxidant, organic dye or
catalyst, thereby avoiding possible errors in the determination of INH and RTH. The statistical parameters
and recovery study data clearly indicate the reproducibility and accuracy of the method. The recommended
procedure is well-suited for the assay and evaluation of drugs in pharmaceutical preparations to assure high
standards of quality control.
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Table 3. Determination of INH/RTH in pharmaceutical preparations

Drug
Isoniazid
Isokin tablet (Warner)
Isokin liquid (Warner)
Isonex tablet (Pfizer)
Solonex tablet (Macleods)
Ipcazide tablet (IPCA)
Ipcazide liquid (IPCA)
Ritodrine
Ritodine tablet (Triokaa)
Ritodine injection (Triokaa)
Yutopar tablet (Duphar-Interfran)
Yutopar injection (Duphar-Interfran)

Label claim
per tablet or
per ml (mg)

Amount of drug found in mg ± SD (n = 5)
Proposed
Official
method
method17,18 t value F value

100
20
100
300
100
300
100
20

99.6 ± 0.4
19.5 ± 0.3
99.7 ± 0.3
299.2 ± 0.4
99.7 ± 0.3
298.5 ± 0.4
99.2 ± 0.3
20.2 ± 0.3

99.4 ± 0.5
19.4 ± 0.5
99.5 ± 0.4
299.0 ± 0.5
99.4 ± 0.5
298.3 ± 0.5
99.0 ± 0.4
20.4 ± 0.5

1.396
0.767
1.789
1.396
2.301
1.396
1.789
1.534

1.56
2.78
1.78
1.56
2.78
1.56
1.78
2.78

10
10
10
10

9.95 ±
9.95 ±
9.90 ±
9.92 ±

9.92
9.92
9.92
9.95

±
±
±
±

2.095
2.301
1.789
2.684

1.56
2.78
1.78
1.78

0.4
0.5
0.4
0.3

0.5
0.3
0.3
0.4
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